BackG1 Therapeutics Overview

G1 Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GTHX.

Quarterly EBIT

-$3.54M
↓ 127.77% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$38.01M
↑ 41.93% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin